Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
xcellerated t cells (2 trials)
Lymphoma (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Multiple Myeloma (Phase 2)
Neoplasms, Plasma Cell (Phase 2)
Trials (2 total)
Trial APIs (1 total)